title: Pharmacokinetics and safety of a single intravenous dose of the antibiotic tigecycline in patients with cirrhosis.
authors.affiliation: Clinical Pharmacology, Pfizer, 500 Arcola Road, Collegeville, PA 19426, USA. korthbj@wyeth.com
authors.forename: Joan M
authors.initials: JM
authors.lastname: Korth-Bradley
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Baird-Bellaire
authors.forename: Alain A
authors.initials: AA
authors.lastname: Patat
authors.forename: Steven M
authors.initials: SM
authors.lastname: Troy
authors.forename: Gabriele M
authors.initials: GM
authors.lastname: Böhmer
authors.forename: Christoph H
authors.initials: CH
authors.lastname: Gleiter
authors.forename: Reinhild
authors.initials: R
authors.lastname: Buecheler
authors.forename: Marsha Y
authors.initials: MY
authors.lastname: Morgan
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008103:Liver Cirrhosis / Q000150:complications* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D012720:Severity of Illness Index; D000078304:Tigecycline
chemical_list: D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline